Iodothyronine 5'-deiodinase (5'D) of mouse brown adipocytes differentiated in cell culture was characterized in detail with respect to the adrenergic control of its biosynthesis. The stimulation of 5'D required mRNA and protein synthesis and was dependent on the stage of differentiation of the cells. The maximum induction was observed around confluence (7-day-old cells), in pre- and post-confluent cells the 5'D activity was significantly less induced. The transient responsiveness of brown fat-cells to the stimulatory effect of adrenergic agents was reflected also in the time course of the induction of 5'D by different concentrations of agonists. The maximum response occurred regularly after an 8 h incubation and implicated a rather fast turnover of the induced enzyme. On the basis of the inhibitory effects of cycloheximide and actinomycin D, the half-life of the induced 5'D and its mRNA were estimated to be 1.5 and 3.3 h respectively. The noradrenaline-induced 5'D activity was shown to be that of the type II enzyme, insensitive to propylthiouracil (PTU). The estimated values of its apparent Km for thyroxine, Km for the co-substrate dithiothreitol, and Vmax. in the presence of 1 mM PTU were 2 nM, 2.6 mM, and 0.1 pmol of I-/h per mg of protein respectively. The 5'D activity was effectively induced by forskolin and dibutyryl cyclic AMP, as well as by isoprenaline, noradrenaline and CGP-12177, but not by phenylephrine, cirazoline or oxymetazoline. This indicates that, contrary to previous observations in vivo, stimulation of 5'D in cultured brown fat-cells involves elevated cyclic AMP levels and is mediated predominantly via beta-receptors, particularly via the so-called beta 3-adrenoceptors.

Institute of Physiology Czech Academy of Sciences Prague Czech Republic

Zobrazit více v PubMed

Am J Physiol. 1987 Dec;253(6 Pt 1):C889-94 PubMed

Am J Physiol. 1987 Sep;253(3 Pt 1):E255-63 PubMed

Mol Endocrinol. 1988 Aug;2(8):706-13 PubMed

Am J Physiol. 1989 Jan;256(1 Pt 1):E74-9 PubMed

Biochem J. 1989 Apr 15;259(2):555-9 PubMed

Biochem J. 1989 Jul 15;261(2):401-5 PubMed

Endocrinology. 1989 Nov;125(5):2502-9 PubMed

Proc Nutr Soc. 1989 Jul;48(2):215-23 PubMed

Endocrinology. 1990 Apr;126(4):1950-8 PubMed

Biochim Biophys Acta. 1990 Jul 25;1018(2-3):243-7 PubMed

J Biol Chem. 1990 Sep 25;265(27):16464-71 PubMed

FEBS Lett. 1990 Nov 12;274(1-2):185-8 PubMed

J Biol Chem. 1990 Dec 25;265(36):22204-9 PubMed

Am J Physiol. 1991 Feb;260(2 Pt 1):E226-31 PubMed

J Biol Chem. 1992 Jan 25;267(3):2006-13 PubMed

Am J Physiol. 1992 Jan;262(1 Pt 1):E58-67 PubMed

Biochem J. 1992 Jun 1;284 ( Pt 2):393-8 PubMed

J Biol Chem. 1951 Nov;193(1):265-75 PubMed

J Clin Invest. 1982 May;69(5):1176-84 PubMed

Proc Natl Acad Sci U S A. 1982 Aug;79(16):5080-4 PubMed

Endocrinology. 1983 Mar;112(3):1153-5 PubMed

Nature. 1983 Oct 20-26;305(5936):712-3 PubMed

Exp Cell Res. 1983 Nov;149(1):105-18 PubMed

Physiol Rev. 1984 Jan;64(1):1-64 PubMed

Nature. 1984 May 10-16;309(5964):163-5 PubMed

Essays Biochem. 1985;20:110-64 PubMed

Am J Physiol. 1986 Jul;251(1 Pt 1):E1-7 PubMed

Biochem Biophys Res Commun. 1986 Jun 13;137(2):863-8 PubMed

Am J Physiol. 1986 Dec;251(6 Pt 1):E639-43 PubMed

Biochim Biophys Acta. 1986 Dec 19;889(3):366-73 PubMed

J Clin Invest. 1987 Jan;79(1):295-300 PubMed

Endocrinology. 1987 Mar;120(3):1069-72 PubMed

Biochim Biophys Acta. 1987 Feb 20;923(2):233-40 PubMed

Endocrinology. 1988 Sep;123(3):1577-81 PubMed